EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Adaptive Platform Trials in Stroke

Elizabeth Lorenzi iD, Amy M Crawford iD, Craig S Anderson iD, Bijoy Menon, Xiaoying Chen iD, Eva Mistry iD, Pooja Khatri iD, Jordan J Elm iD, Jonathan Beall, Benjamin R Saville iD, Scott M Berry iD, Roger J Lewis iD

Stroke · 2025-01 · 56 (1) · 198-208

DOI: 10.1161/strokeaha.124.045754 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stroke, 2025-01. Verfasst von Elizabeth Lorenzi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Berry Consultants LLC, Austin, TX (E.L., A.M.C., S.M.B., R.J.L.). Hauptthemen laut MEDLINE: Stroke, Thrombectomy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical trials of treatments for stroke have generally utilized 2-arm, randomized designs to evaluate a single intervention against a control. Running separate clinical trials, with each addressing a single therapeutic question, is resource intensive and slows evidence generation, especially in a field with rapidly expanding treatment options and evolving practices. Platform trials—randomized clinical trials designed to evaluate multiple interventions that may enter and exit the ongoing platform based on a master protocol—accelerate the investigation of multiple therapeutic options within a single infrastructure. This in turn has the potential to accelerate access to new interventions for patients with stroke that can save lives and improve outcomes. In the context of acute ischemic stroke, 2 new platform trials have been established, the STEP trial (StrokeNet Thrombectomy Endovascular Platform) and ACT-GLOBAL (A Multi-Factorial, Multi-Arm, Multi-Stage, Randomised, Global Adaptive Platform Trial for Stroke), to address multiple therapeutic questions simultaneously using a multifactorial design including Bayesian modeling and other adaptive features. These trials are designed to maximize the information obtained from each participant, to align clinical research more closely with the complexities of clinical care, and to accelerate the identification of effective therapies. This article explores conceptual, practical, and statistical considerations in the design and implementation of adaptive platform trials and highlights their potential to accelerate the identification of new therapies, management, and rehabilitation in stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeThrombectomyHumansRandomized Controlled Trials as TopicIschemic StrokeResearch DesignBayes TheoremEndovascular ProceduresAdaptive Clinical Trials as Topic

Stichwörter der Autor:innen

Bayesian analysisadaptive clinical trialsrandomized control trialsresearch designstroke

Autor:innen und Institutionen

  • Berry Consultants LLC, Austin, TX (E.L., A.M.C., S.M.B., R.J.L.).
  • George Institute for Global Health, University of New South Wales, Sydney, Australia (C.S.A., X.C.).
  • Institute for Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China (C.S.A.).
  • Department of Clinical Neurosciences, Radiology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada (B.M.).
  • Department of Neurology and Rehabilitation Medicine, University of Cincinnati, OH (E.M., P.K.).
  • Department of Public Health Sciences, Medical University of South Carolina, Charleston (J.J.E., J.B.).

ORCID-Profile: Elizabeth Lorenzi, Amy M Crawford, Craig S Anderson, Xiaoying Chen, Eva Mistry, Pooja Khatri, Jordan J Elm, Benjamin R Saville, Scott M Berry, Roger J Lewis

Förderung

  • NINDS NIH HHS

Zitieren

APA

Lorenzi, E., Crawford, A. M., Anderson, C. S., Menon, B., Chen, X., Mistry, E., Khatri, P., Elm, J. J., Beall, J., Saville, B. R., Berry, S. M., & Lewis, R. J. (2025). Adaptive Platform Trials in Stroke. Stroke, 56(1), 198-208. https://doi.org/10.1161/strokeaha.124.045754

Vancouver

Lorenzi E, Crawford AM, Anderson CS, Menon B, Chen X, Mistry E, et al. Adaptive Platform Trials in Stroke. Stroke. 2025;56(1):198-208. doi:10.1161/strokeaha.124.045754

BibTeX
@article{Lorenzi2025,
  author = {Lorenzi, Elizabeth and Crawford, Amy M and Anderson, Craig S and Menon, Bijoy and Chen, Xiaoying and Mistry, Eva and Khatri, Pooja and Elm, Jordan J and Beall, Jonathan and Saville, Benjamin R and Berry, Scott M and Lewis, Roger J},
  title = {Adaptive Platform Trials in Stroke},
  journal = {Stroke},
  year = {2025},
  volume = {56},
  number = {1},
  pages = {198--208},
  doi = {10.1161/strokeaha.124.045754}
}
Kostenlos starten →